1h Free Analyst Time
The high performance biomaterials market is forecasted to grow by USD 8.48 bn during 2023-2028, accelerating at a CAGR of 11.29% during the forecast period. The report on the high performance biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of musculoskeletal diseases and disorders, rising prevalence of dental diseases and related risk factors, and surging number of joint replacement and arthroplasty surgeries.
The high performance biomaterials market is segmented as below:
By Type
- Metallic
- Polymers
- Ceramic
By Application
- Orthopedics
- Dental
- Cardiovascular
- Plastic surgery
- Tissue engineering and others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the high performance biomaterials market covers the following areas:
- High performance biomaterials market sizing
- High performance biomaterials market forecast
- High performance biomaterials market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global high performance biomaterials market: Advanced Medical Solutions Group Plc, Arctic Biomaterials Oy Ltd, BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, CoorsTek Inc., Corbion nv, Covestro AG, Dentsply Sirona Inc., Evonik Industries AG, Himed LLC, Honeywell International Inc., Koninklijke DSM NV, Regenity Biosciences, RevBio Inc., Solesis, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc., and ZimVie Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is development of high-performance biomaterials in tissue engineering.'
According to the report, one of the major drivers for this market is the increasing prevalence of musculoskeletal diseases and disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group Plc
- Arctic Biomaterials Oy Ltd
- BASF SE
- Berkeley Advanced Biomaterials
- CAM Bioceramics BV
- CoorsTek Inc.
- Corbion nv
- Covestro AG
- Dentsply Sirona Inc.
- Evonik Industries AG
- Himed LLC
- Honeywell International Inc.
- Koninklijke DSM NV
- Regenity Biosciences
- RevBio Inc.
- Solesis
- Stryker Corp.
- Victrex Plc
- Zimmer Biomet Holdings Inc.
- ZimVie Inc.
